NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia

Status:
RECRUITING

Trial end date:
2031-12-01

Target enrollment:

Participant gender:

This study will evaluate the long-term safety of NBI-1117568 in adults with schizophrenia.

PHASE3

Neurocrine Biosciences